Michael R. Megna - 04 Oct 2021 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
Chief Accounting Officer
Signature
/s/ Michael R. Megna
Issuer symbol
KNSA
Transactions as of
04 Oct 2021
Net transactions value
$0
Form type
4
Filing time
06 Oct 2021, 16:51:35 UTC
Previous filing
07 Sep 2021
Next filing
23 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Units Award $0 +700 $0.000000 700 04 Oct 2021 Class A Common Shares 700 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F2 The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021.